# NEWAMSTERDAM PHARMA COMPANY (NAMS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NAMS/

- Reporting holders: 1
- Reported value: $24.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $24.7K | 1,017 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $24.7K |
| Q2 2026 | 202 | $4.3B |
| Q1 2026 | 174 | $4.0B |
| Q4 2025 | 187 | $4.2B |
| Q3 2025 | 140 | $3.5B |
| Q2 2025 | 132 | $2.1B |
| Q1 2025 | 128 | $2.3B |
| Q4 2024 | 133 | $2.6B |
| Q3 2024 | 102 | $1.3B |
| Q2 2024 | 91 | $1.4B |
| Q1 2024 | 76 | $1.7B |
| Q4 2023 | 34 | $708.2M |